Why is Balaxi Pharma falling/rising?

As of 22-Sep, Balaxi Pharmaceuticals Ltd is experiencing a price increase, currently at 47.01, with a change of 0.24, representing a rise of 0.51%. The stock's performance today is in line with its sector, and it is trading above its 5-day and 20-day moving averages, although it remains below its 50-day, 100-day, and 200-day moving averages. Notably, there has been a significant increase in investor participation, with delivery volume rising by 49.62% against the 5-day average. However, the stock has shown a substantial decline over the longer term, with a year-to-date decrease of 34.99% and a one-year decline of 57.58%. There are no specific positive or negative factors available to further explain the stock's recent movement.
In the broader market context, Balaxi Pharmaceuticals has outperformed the benchmark Sensex in the short term, with a one-week return of 3.80% compared to the Sensex's 0.53%. However, the stock's year-to-date performance remains significantly lower than the benchmark, which has gained 6.59% during the same period. This contrast highlights the challenges faced by Balaxi Pharmaceuticals despite its recent uptick in price, as it continues to struggle with long-term performance relative to the broader market.